Literature DB >> 10573341

Congenital pseudarthrosis of the tibia: a retrospective review.

J A Traub1, W O'Connor, P D Masso.   

Abstract

Treatment of congenital pseudarthrosis of the tibia has been notoriously very difficult. This retrospective review of 36 cases (33 patients) seen at the Shriners Hospital (Springfield, Massachusetts Unit), from 1927 to the present evaluates the different forms of treatment and their long-term results. Adequate information was obtained from 30 patients (33 cases) to include them in this study. Twenty-nine patients (32 cases) underwent 154 surgical procedures, of which 138 were to achieve union of the pseudarthrosis (4.3 per case), and one parent could not recall how many surgeries were performed on her son. Sixteen surgeries were performed to correct leg-length discrepancy. Four cases healed with bracing alone. Of the 30 patients (33 cases), 14 patients (15 cases) required amputation. These patients had undergone multiple attempts at union (average, 4.7 procedures). Patients who went on to union averaged 2.8 surgical procedures. Even with newer techniques available to the trained pediatric orthopaedist, treatment of congenital pseudarthrosis of the tibia remains an elusive problem.

Entities:  

Mesh:

Year:  1999        PMID: 10573341

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  9 in total

1.  Bone morphogenetic protein-2 for the treatment of congenital pseudarthrosis of the tibia or persistent tibial nonunion in children and adolescents: A retrospective study with a minimum 2-year follow-up.

Authors:  Tim N Hissnauer; Norbert Stiel; Kornelia Babin; Martin Rupprecht; Michael Hoffmann; Johannes M Rueger; Ralf Stuecker; Alexander S Spiro
Journal:  J Mater Sci Mater Med       Date:  2017-02-17       Impact factor: 3.896

2.  Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia.

Authors:  Oliver Birke; Aaron Schindeler; Manoj Ramachandran; Chris T Cowell; Craig F Munns; Michael Bellemore; David G Little
Journal:  J Child Orthop       Date:  2010-10-21       Impact factor: 1.548

3.  Successful treatment of congenital pseudarthrosis of the tibia: still a challenge.

Authors:  K Bobotas; S N Lallos; V S Nikolaou; D S Kοrres; N E Efstathopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-09-02

4.  Health-related quality of life measures in genetic disorders: an outcome variable for consideration in clinical trials.

Authors:  David A Stevenson; John C Carey
Journal:  Am J Med Genet C Semin Med Genet       Date:  2009-08-15       Impact factor: 3.908

5.  Effectiveness of recombinant human bone morphogenetic protein-7 in the management of congenital pseudoarthrosis of the tibia: a randomised controlled trial.

Authors:  Sakti Prasad Das; Shankar Ganesh; Sudhakar Pradhan; Deepak Singh; Ram Narayan Mohanty
Journal:  Int Orthop       Date:  2014-05-15       Impact factor: 3.075

6.  Analysis of radiographic characteristics of anterolateral bowing of the leg before fracture in neurofibromatosis type 1.

Authors:  David A Stevenson; John C Carey; David H Viskochil; Laurie J Moyer-Mileur; Hillarie Slater; Mary A Murray; Jacques L D'Astous; Kathleen A Murray
Journal:  J Pediatr Orthop       Date:  2009-06       Impact factor: 2.324

7.  Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.

Authors:  Weixi Wang; Jeffry S Nyman; Heather E Moss; Gloria Gutierrez; Gregory R Mundy; Xiangli Yang; Florent Elefteriou
Journal:  J Bone Miner Res       Date:  2010-07       Impact factor: 6.741

8.  Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) for the Treatment of Nonunion of the Femur in Children and Adolescents: A Retrospective Analysis.

Authors:  Tim N Hissnauer; Norbert Stiel; Kornelia Babin; Martin Rupprecht; Karsten Ridderbusch; Johannes M Rueger; Ralf Stuecker; Alexander S Spiro
Journal:  Biomed Res Int       Date:  2017-03-02       Impact factor: 3.411

9.  Orthopaedic manifestations of neurofibromatosis type 1: A case report.

Authors:  Florentina Năstase; Diana Sabina Radaschin; Elena Niculeț; Andrei Vlad Brădeanu; Mădălina Codruța Verenca; Aurel Nechita; Valentin Chioncel; Lawrence Chukwudi Nwabudike; Liliana Baroiu; Eduard Drima Polea; Silvia Fotea; Lucretia Anghel; Alexandru Nechifor; Alin Laurenţiu Tatu
Journal:  Exp Ther Med       Date:  2021-12-13       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.